Pomalidomide with dexamethasone in relapsed/refractory multiple myeloma with renal impairment

Pomalidomide with dexamethasone in relapsed/refractory multiple myeloma with renal impairment

Melflufen and dexamethasone vs pomalidomide and dexamethasone in relapsed refractory multiple my...Подробнее

Melflufen and dexamethasone vs pomalidomide and dexamethasone in relapsed refractory multiple my...

Pomalidomide and low-dose dexamethasone for relapsed or refractory multiple myelomaПодробнее

Pomalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma

Pomalidomide + Low-Dose Dexamethasone in Refractory or Relapsed & Refractory MM and Renal ImpairmentПодробнее

Pomalidomide + Low-Dose Dexamethasone in Refractory or Relapsed & Refractory MM and Renal Impairment

ASH 2014: Phase I MM-008 study of pomalidomide in myeloma with renal impairmentПодробнее

ASH 2014: Phase I MM-008 study of pomalidomide in myeloma with renal impairment

Pomalidomide + Low-Dose Dexamethasone in Refractory or Relapsed & Refractory MM and Renal ImpairmentПодробнее

Pomalidomide + Low-Dose Dexamethasone in Refractory or Relapsed & Refractory MM and Renal Impairment

Case 3: Elderly Double Refractory Patient with Renal ImpairmentПодробнее

Case 3: Elderly Double Refractory Patient with Renal Impairment